ReachBio will be exhibiting at this year’s ToxExpo at the Society of Toxicology (SOT) 58th Annual Meeting in Baltimore, Maryland. Stop by our booth, #4121, to learn about our latest assays to help address your labs program challenges. Since 2007, we have worked with hundreds of companies to advance their understanding of the potency, efficacy and toxicity of their leading candidate therapies. You will also have the opportunity to view our debut video that will be running on a monitor at our booth.
Please join us for the platform presentation session which provides an in-depth look at a co-publication between MedImmune and ReachBio.
Abstract 3297
“Impact of Monoclonal Antibody (MoAb), Payload and Linker Structure in Antibody Drug Conjugates (ADCs) on Primitive Myeloid Progenitors (CFU-GM), or Mature Neutrophil Cytotoxicity”
Date: Thursday, March 14, 2019
Time: 9:00 AM-9:15 AM
Where: CC Room 321
Our CSO, Dr. Emer Clarke thoroughly enjoyed working on this project in tandem with Pauline Ryan from MedImmune, which is the biologics research and development arm of AstraZeneca. Mrs. Ryan will be presenting their abstract on Thursday morning at the Baltimore Convention Center. Both she and Dr. Clarke will be available to answer any questions or discuss the abstract after the presentation.
